A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs

Martine Bagot; Baktiar Hasan; Sean Whittaker; Marie Beylot-Barry; Robert Knobler; Emad Shah; Sandrine Marreaud; Stephen Morris; Stephane Dalle; Octavio Servitje; Richard Cowan; Liisa Vakeva; Guillaume Chaby; Constanze Jonak; Christopher P. Fox; Diana Ritchie; Maarten H. Vermeer; Rudolf Stadler; Pablo L. Ortiz Romero; Julia Scarisbrick; Pietro Quaglino; EORTC Cutaneous T- Cell Lymp

doi:10.1684/ejd.2017.3008

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs

Martine Bagot, Baktiar Hasan, Sean Whittaker, Marie Beylot-Barry, Robert Knobler, Emad Shah, Sandrine Marreaud, Stephen Morris, Stephane Dalle, Octavio Servitje, Richard Cowan, Liisa Vakeva, Guillaume Chaby, Constanze Jonak, Christopher P. Fox, Diana Ritchie, Maarten H. Vermeer, Rudolf Stadler, Pablo L. Ortiz Romero, Julia ScarisbrickPietro Quaglino, EORTC Cutaneous T- Cell Lymp

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Tidskrift	European Journal of Dermatology
Volym	27
Utgåva	3
Sidor (från-till)	286-294
Antal sidor	9
ISSN	1167-1122
DOI	https://doi.org/10.1684/ejd.2017.3008
Status	Publicerad - maj 2017
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

3121 Inre medicin

Åtkomst av dokument

10.1684/ejd.2017.3008

Citera det här

Bagot, M., Hasan, B., Whittaker, S., Beylot-Barry, M., Knobler, R., Shah, E., Marreaud, S., Morris, S., Dalle, S., Servitje, O., Cowan, R., Vakeva, L., Chaby, G., Jonak, C., Fox, C. P., Ritchie, D., Vermeer, M. H., Stadler, R., Ortiz Romero, P. L., ... EORTC Cutaneous T- Cell Lymp (2017). A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs. European Journal of Dermatology, 27(3), 286-294. https://doi.org/10.1684/ejd.2017.3008

Bagot, Martine ; Hasan, Baktiar ; Whittaker, Sean ; Beylot-Barry, Marie ; Knobler, Robert ; Shah, Emad ; Marreaud, Sandrine ; Morris, Stephen ; Dalle, Stephane ; Servitje, Octavio ; Cowan, Richard ; Vakeva, Liisa ; Chaby, Guillaume ; Jonak, Constanze ; Fox, Christopher P. ; Ritchie, Diana ; Vermeer, Maarten H. ; Stadler, Rudolf ; Ortiz Romero, Pablo L. ; Scarisbrick, Julia ; Quaglino, Pietro ; EORTC Cutaneous T- Cell Lymp. / A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656) : results and lessons learned for future trial designs. I: European Journal of Dermatology. 2017 ; Vol. 27, Nr. 3. s. 286-294.

@article{8a93e052ab9f4193b153c6cb580ce471,

title = "A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs",

keywords = "cutaneous T-cell lymphoma, maintenance treatment, randomized trial, lenalinomide, anti-angiogenic, MYCOSIS FUNGOIDES/SEZARY-SYNDROME, SEZARY-SYNDROME, INTERNATIONAL-SOCIETY, TASK-FORCE, CLASSIFICATION, ORGANIZATION, SURVIVAL, PROPOSAL, OUTCOMES, DISEASE, 3121 Internal medicine",

author = "Martine Bagot and Baktiar Hasan and Sean Whittaker and Marie Beylot-Barry and Robert Knobler and Emad Shah and Sandrine Marreaud and Stephen Morris and Stephane Dalle and Octavio Servitje and Richard Cowan and Liisa Vakeva and Guillaume Chaby and Constanze Jonak and Fox, {Christopher P.} and Diana Ritchie and Vermeer, {Maarten H.} and Rudolf Stadler and {Ortiz Romero}, {Pablo L.} and Julia Scarisbrick and Pietro Quaglino and {EORTC Cutaneous T- Cell Lymp}",

year = "2017",

month = may,

doi = "10.1684/ejd.2017.3008",

language = "English",

volume = "27",

pages = "286--294",

journal = "European Journal of Dermatology",

issn = "1167-1122",

publisher = "JOHN LIBBEY EUROTEXT LTD",

number = "3",

}

Bagot, M, Hasan, B, Whittaker, S, Beylot-Barry, M, Knobler, R, Shah, E, Marreaud, S, Morris, S, Dalle, S, Servitje, O, Cowan, R, Vakeva, L, Chaby, G, Jonak, C, Fox, CP, Ritchie, D, Vermeer, MH, Stadler, R, Ortiz Romero, PL, Scarisbrick, J, Quaglino, P & EORTC Cutaneous T- Cell Lymp 2017, 'A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs', European Journal of Dermatology, vol. 27, nr. 3, s. 286-294. https://doi.org/10.1684/ejd.2017.3008

A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656) : results and lessons learned for future trial designs. / Bagot, Martine; Hasan, Baktiar; Whittaker, Sean; Beylot-Barry, Marie; Knobler, Robert; Shah, Emad; Marreaud, Sandrine; Morris, Stephen; Dalle, Stephane; Servitje, Octavio; Cowan, Richard; Vakeva, Liisa; Chaby, Guillaume; Jonak, Constanze; Fox, Christopher P.; Ritchie, Diana; Vermeer, Maarten H.; Stadler, Rudolf; Ortiz Romero, Pablo L.; Scarisbrick, Julia; Quaglino, Pietro; EORTC Cutaneous T- Cell Lymp.

I: European Journal of Dermatology, Vol. 27, Nr. 3, 05.2017, s. 286-294.

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

TY - JOUR

T1 - A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656)

T2 - results and lessons learned for future trial designs

AU - Bagot, Martine

AU - Hasan, Baktiar

AU - Whittaker, Sean

AU - Beylot-Barry, Marie

AU - Knobler, Robert

AU - Shah, Emad

AU - Marreaud, Sandrine

AU - Morris, Stephen

AU - Dalle, Stephane

AU - Servitje, Octavio

AU - Cowan, Richard

AU - Vakeva, Liisa

AU - Chaby, Guillaume

AU - Jonak, Constanze

AU - Fox, Christopher P.

AU - Ritchie, Diana

AU - Vermeer, Maarten H.

AU - Stadler, Rudolf

AU - Ortiz Romero, Pablo L.

AU - Scarisbrick, Julia

AU - Quaglino, Pietro

AU - EORTC Cutaneous T- Cell Lymp

PY - 2017/5

Y1 - 2017/5

KW - cutaneous T-cell lymphoma

KW - maintenance treatment

KW - randomized trial

KW - lenalinomide

KW - anti-angiogenic

KW - MYCOSIS FUNGOIDES/SEZARY-SYNDROME

KW - SEZARY-SYNDROME

KW - INTERNATIONAL-SOCIETY

KW - TASK-FORCE

KW - CLASSIFICATION

KW - ORGANIZATION

KW - SURVIVAL

KW - PROPOSAL

KW - OUTCOMES

KW - DISEASE

KW - 3121 Internal medicine

U2 - 10.1684/ejd.2017.3008

DO - 10.1684/ejd.2017.3008

M3 - Article

VL - 27

SP - 286

EP - 294

JO - European Journal of Dermatology

JF - European Journal of Dermatology

SN - 1167-1122

IS - 3

ER -

Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E et al. A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs. European Journal of Dermatology. 2017 maj;27(3):286-294. https://doi.org/10.1684/ejd.2017.3008